Low-amplitude GPi stimulation inhibited the thalamic neurons ... It is likely that the modulation comes about through the local effects of the DBS electrode on the neural activity in the DBS ...

(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and the globus pallidus pars interna (GPi) has been shown ... worsening of levodopa response, with electrodes implanted in the caudal ...

For some dystonic patients, it remains difficult to know whether they represent good candidates for DBS. Therefore ... the motor and limbic parts of the GPi). This will again need well-designed ...

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for ...

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...

Carnegie Mellon researchers developed "DeepFocus," a new method for brain stimulation that combines transnasal and transcranial electrical stimulation for minimally invasive targeting of deep brain ...

Deep Brain Stimulation (DBS) has emerged as a leading treatment option for patients suffering from medically refractory dystonia, a movement disorder characterized by involuntary muscle contractions.